Investors & Media

Corporate Profile

Millendo Therapeutics is a biopharmaceutical company primarily focused on developing novel treatments for endocrine diseases. We create distinct and transformative treatments for endocrine diseases where there is a significant unmet medical need.  

Corporate Presentation

More information is coming soon.

Stock Quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Webcast

More events are coming soon.

Upcoming Events

There are no upcoming events available at this time.
More Events

Millendo in the News

January 5, 2021

Millendo Therapeutics Provides Pipeline and Business Update

Read More

November 9, 2020

Millendo Therapeutics Reports Third Quarter 2020 Operating and Financial Results

Read More

September 24, 2020

Millendo Therapeutics Announces Initiation of First-in-Human Clinical Trial of MLE-301, a Selective NK3R Antagonist

Read More